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Mother-to-child transmission (MTCT) of human immunodeficiency virus type 1 (HIV-1) through breast milk is a significant mechanism
of infection in many regions of the world. We compared the HIV-1 populations in paired blood and breast milk samples using a heteroduplex
tracking assay (HTA) for the V1/V2 regions of env (V1/V2-HTA). V1/V2-HTA patterns were similar in the eight pairs of samples for which
adequate template sampling could be demonstrated. No unique variants existed in either compartment, and differences detected in the relative
abundance of variants between compartments were small, occurred among low abundance variants, and were not statistically significant. We
also documented the impact of template sampling as a limiting feature in comparing two viral populations. The absence of unique variants
and the lack of significant differences in the relative abundance of variants between these compartments support the conclusion that viruses in
the blood plasma and breast milk are well equilibrated.
D 2004 Elsevier Inc. All rights reserved.
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Vertical transmission of human immunodeficiency virus
type-1 (HIV-1) from mother to child is a common source of
pediatric HIV infection (United Nations Children’s Fund
Mother-to-Child Transmission of HIV Fact Sheet [http://
www.unicef.org/publications/index_4414.html]), with
reported frequencies of 13–48% in the absence of antire-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Glaxo-Smith-Kline, RTP, NC 27709-3398, United States.troviral prophylaxis (Thorne and Newell, 2000). Mother-to-
child transmission (MTCT) can occur transplacentally
during pregnancy, during delivery by exposure to infectious
maternal blood or mucosal surfaces, or after delivery through
HIV-containing breast milk. Breast feeding has been
identified as an important route for vertical transmission of
HIV-1, particularly in regions of the world where interven-
tions such as antiretroviral therapy and infant formula are not
widely available (Dunn et al., 1992; John et al., 2001; Nduati
et al., 2000; Oxtoby, 1988; Van de Perre et al., 1993). Both
cell-free virus particles and HIV-1-infected cells have been
found in breast milk (Lewis et al., 1998; Van de Perre et al.,
1993) and have been implicated in oral HIV-1 transmission
(Baba et al., 1996; Baron et al., 2000).
Tissue-specific HIV-1 variants have been identified in
various anatomical compartments, including the central04) 295–303
Fig. 1. Subject samples and virus loads. Paired blood and breast milk
samples were obtained with informed consent from women attending a
postnatal clinic at Lilongwe Central Hospital, Lilongwe, Malawi. Virus load
values are plotted as the log10 of the viral RNA copies per milliliter. The
boxes encompass the 25th–75th percentiles with the median values denoted
by a dash (–); bars denote the outer quartiles. Virus load values for blood
plasma (P) and breast milk (B) samples are separated into the eight paired
samples successfully validated for template sampling (+) and the remaining
samples ().
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intestinal tract (for review, see McGrath et al., 2001).
Compartmentalization of viral genotypic variants is
thought to occur due to constraints on viral entry and
replication, target cell differences, and differing immune
pressures in distinct anatomical regions that result in the
independent selection of subsets of the virus population for
continued replication. The potential exists for HIV-1 to
exhibit compartmentalization between breast milk and
other compartments as well. A recent study by Becquart
et al. (2002) suggested that distinct variants do exist in
comparing blood plasma and breast milk. Confirming
whether this is the case is important to understanding the
virologic and immunologic factors that affect postnatal
MTCT.
As part of an effort to understand the determinants of
postnatal vertical transmission, we have examined HIV-1
populations in blood plasma and breast milk in a cross-
sectional analysis to assess whether compartmentalization
occurs. In order to determine whether tissue-specific viral
variants are present, we have compared HIV-1 popula-
tions from these compartments using the heteroduplex
tracking assay (HTA), a sensitive and quantitative
method to detect nucleotide sequence variability in
complex populations (Delwart et al., 1993, 1994;
Kitrinos et al., 2003; Nelson et al., 1997). HTA
evaluation of HIV-1 populations is performed by creating
heteroduplexes between a PCR product generated from
viral RNA and a radiolabeled probe DNA. Nucleotide
and length mismatches between the two strands induce
bends in the duplex that alter its migration rate during
native polyacrylamide gel electrophoresis. Genotypic
variants, represented as discrete heteroduplex bands in
the gel, can then be quantified to compare their relative
abundances.
We have used an HTA specific for variable regions 1 and
2 (V1/V2) of the env gene (V1/V2-HTA; Kitrinos et al.,
2003) to compare HIV-1 populations in paired blood plasma
and breast milk samples. The V1/V2 region was chosen as a
marker for genetic diversity because of its high degree of
variability (Starcich et al., 1986) and the presence of
multiple coexisting variants (Kitrinos et al., 2003). The
presence of multiple variants and their relative abundance
provide a sensitive approximation of the virus population
composition when comparing two compartments, and also
represent a stringent tool for assessing the quality of
template sampling of the virus population. Compartmental-
ization can be recognized by the appearance of distinct
genotypic variants or the selective outgrowth of shared
variants, reflecting the phenotypic differences that are
selected for during compartmentalization. The high degree
of similarity in V1/V2-HTA patterns representing the virus
from blood plasma and breast milk suggests a lack of
compartmentalization between these two compartments.
Quantitative statistical analysis of V1/V2-HTA patterns
further demonstrate that any real differences in thecomposition of virus populations of blood plasma and
breast milk are at most small.Results
Samples and virus loads
The women who participated in this study were part of
a group of 124 lactating women attending a postnatal
clinic at Lilongwe Central Hospital, Lilongwe, Malawi
(Hoffman et al., 2003). From this cohort, 33 women were
identified with anti-HIV-1 antibodies in their blood. The
virus loads of the blood plasma and the skim milk fraction
of the breast milk samples from these subjects were
determined using the Roche Amplicor HIV-1 Monitor and
the NucliSens HIV-1 QT assays, respectively (Fig. 1).
Previous comparison suggests little difference in viral
RNA measurements by these assays (Dyer et al., 1999). Of
these samples, 42% (14 of 33) had no detectable virus in
the skim breast milk, while all but one of the plasma
samples had detectable levels of virus. A subset of 28 skim
breast milk samples and their matched plasma samples was
analyzed. We were able to generate a V1/V2 reverse-
transcriptase (RT)-PCR product from all 28 of the blood
plasma samples, but from only 17 of the 28 breast milk
samples. Of the 17 breast milk samples that were able to
be amplified, only eight generated reproducible V1/V2-
HTA patterns, a measure of efficient RNA template
sampling. The ability to generate RT-PCR products
demonstrating adequate template sampling largely corre-
lated with the sample virus load. The inconsistent
amplification of some breast milk samples raised sampling
error as a major challenge in evaluating virus populations,
Fig. 3. Percent difference comparison of blood plasma and breast milk
samples. Phosphorimager analysis of V1/V2-HTAs was used to determine
the relative abundance of each heteroduplex variant in a sample. The
difference between any two samples was assessed using the percent change
calculation as described. The p1–p2 and m1–m2 values are the difference
calculated between separate amplifications of the same plasma or breast
milk samples, respectively. The p1–m1 and p2–m2 values are the calculated
differences in the abundance of variants between the plasma and breast milk
samples from either the first or the second amplification. The px–py values
represent the difference between pairs of plasma samples from different
subjects as a reference. The median value for all comparisons is denoted by
a dash (–).
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obtained.
V1/V2-HTA
V1/V2-HTA was performed on RT-PCR products from
paired blood plasma and breast milk samples using a
heterologous probe to increase the sensitivity to small
differences between genotypic variants within a population
(Kitrinos et al., 2003). Comparison of the viral variants in
blood plasma and skim breast milk by V1/V2-HTA showed
that all of the major variants could be detected in both
compartments (Fig. 2). It is important to note that the low
intensity of some lanes does not indicate homogeneity, but
rather that different amounts of total PCR product are
present in the samples, which is compensated for by
normalizing to the total signal in each lane (see below).
Samples contained from four to eight heteroduplex bands
representing at least 5% of the signal present in the
respective sample; other bands comprising minor (less than
5%) populations were also present in some samples. Each
subject’s heteroduplex pattern was unique, representing
viral sequences unique to that subject. As a control to
confirm adequate template sampling, duplicate RT-PCR
reactions of each sample were compared. Because the
reproduction of complex HTA patterns by two independent
RT-PCR amplifications is unlikely to occur by chance, we
interpret the reproduction of these patterns as an indication
that all of the major genotypic variants present were
adequately sampled. Only those samples that could be
validated in this manner were included in our analysis.
Heteroduplex quantitation and statistical analysis
Phosphorimager analysis of V1/V2-HTAs was used to
quantitate the relative abundance of each heteroduplex
variant in a sample. The relative abundance values thus
measured are directly related to the abundance of each
genotypic variant present in a sample and therefore
represent their frequency in the virus population of that
sample. The difference between any two samples wasFig. 2. V1/V2-HTA comparing paired blood plasma and breast milk samples. V1/
and breast milk (M) samples using a heterologous HIV-1 clade C V1/V2 env probe
The single-stranded radiolabeled probe (ss) is present in each lane.assessed using the percent change calculation, a method
used to characterize the difference between two populations
in the context of HTA analysis (Kitrinos et al., 2003; Nelson
et al., 2000), with bands present at less than 5% relative
abundance being discarded.
To assess the variability inherent in our analysis, the
percent difference between the repeated measurements of
the plasma samples (p1–p2) and the repeated measurements
of the breast milk (m1–m2) was calculated (Fig. 3). Because
each sample is taken from the same source, the theoretical
difference between the repeated experiments is zero. The
median percent difference for the repeated analysis of breast
milk samples was 11%, and this was significantly higher
than the percent difference for blood plasma (6%) (P =
0.032). The greater variability observed in the repeatedV2-HTA was performed on HIV-1 sequences from paired blood plasma (P)
. Paired samples are in adjacent lanes, with the subject identifier above them.
Fig. 4. Sampling reproducibility is reduced for less abundant variants. As a
second measure of the difference in the relative abundance of variants, the
ratio of the repeated breast milk measurements (m1/m2) for each variant
and the average ratio of the blood plasma and breast milk abundances for
each variant (p/m) were compared to the average relative abundance of that
variant. In this comparison, those variants present at high relative
abundances (N0.3) are measured consistently (the ratio of measurements
approaches 1.0), while those variants present at lower relative abundances
are measured with less consistency (ranging from near 1.0 to approximately
0.5). This pattern suggests that the largest degree of variability in measuring
the relative abundance of a variant is for those that exist at lower relative
abundances. The distribution pattern of the differences between the plasma
and breast milk variants (p/m) is similar to that for repeated breast milk
samples. This suggests that differences in the abundance of variants
between these two compartments are largely related to those of the repeated
measurements and likely stem from experimental variability.
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sampling of the viral genotypes) is likely due to lower virus
load or reduced efficiency in the RT-PCR step with RNA
from this source. As a control, the comparison of two
samples from different populations (px–py) gave percent
difference values near 100%.
The percent difference between the virus populations in
the blood plasma and breast milk was calculated in the same
manner for both analyses of these samples (p1–m1, p2–m2;
Fig. 3). These differences were small, generally less than
20%, and were not significantly different from one another
by a rank sum test (P = 0.221), indicating that the percent
difference measurement between the two compartments was
made consistently.
Finally, to determine whether the difference in the
abundance of variants between compartments was signifi-
cant, the rank sum test was used to compare the two
measures of assay variability (p1–p2, m1–m2) and the
potential compartmental difference (p1–m1, p2–m2). A
significant difference was found between the compartmental
percent difference (p1–m2, p2–m2) and the repeated plasma
analysis (p1–p2) (P = 0.002). However, the percent differ-
ence between the repeated breast milk analysis (m1–m2)
and the compartmental percent difference measurements
was not significant (P = 0.065). Therefore, the differences in
the relative abundance of HIV-1 variants present in the
blood and the breast milk were not significantly greater than
those measured for the repeated analysis of the breast milk
samples alone. Furthermore, the magnitude of the differ-
ences observed are relatively small, with median values in
the two plasma-breast milk comparisons of approximately
15% difference, of which at least 10% is likely contributed
by assay variability.
As a second measure of the difference in the relative
abundance of variants, we compared the ratio of the
repeated breast milk measurements (m1:m2) and the
averaged ratio of the blood plasma and breast milk
measurements (p/m) to the relative abundance of each
variant (Fig. 4). If the relative abundance of a variant was
fully reproduced between the two analyses, this value would
be 1. We found that the largest variability in abundance
measurements occurred for rare variants. This is likely due
to the fact that variants present at lower relative abundances
are more difficult to sample consistently, such that sampling
error is more pronounced in measuring these variants. We
also note that the distribution of the differences between the
plasma and breast milk variants (p:m) and those of the
repeated breast milk samples (m1:m2) are similar. This
suggests that the small differences we measured between
these two compartments are related to those of the repeated
measurements and likely stem from experimental variability.
Together, the absence of a significant difference in the
identity and relative abundance of variants between blood
and breast milk, and the similar distribution of the differ-
ences that were detected to those that occur due to
experimental variability, suggest an absence of compart-mentalization as defined by the absence of a compartment-
specific outgrowth of either unique or shared variants.
The effects of sampling error on the inference of population
composition
To assess the effects of sampling error on evaluations of
virus population composition, we examined the effects of
sample size in three settings: (i) the ability to accurately
assign a relative abundance to a variant within a population;
(ii) the apparent difference measured between two identical
populations; and (iii) the impact of undersampling in the
context of an HTA experiment.
To simulate the process of sampling a virus population,
we created a large starting population composed of four
bgenotypic variantsQ having the frequencies of 50%, 25%,
15%, and 10%. Samples of N elements (genomes) were
chosen at random from this population and the frequency
of each variant calculated, simulating the process of
template utilization during RT-PCR amplification. This
process was repeated 104 times for values of N ranging
from 101 to 103, and 95% confidence intervals were
determined for each distribution (Fig. 5A). This simu-
lation illustrates the effects of small sample sizes on
estimates of population structure: the three variants
displayed in Fig. 5A cannot be shown to exist at different
 Fig. 5. Effects of sample size on evaluations of population composition. (A) A population of 107 elements composed of four bvariantsQ at frequencies of 50%,
25%, 15%, and 10% was constructed from which samples of size N ranging from 101 to 103 (indicated by circles along the x-axis) were randomly chosen. By
iterating this process 104 times for each value of N, a distribution of values for the frequency of each variant was generated. Solid lines encompass 95% of the
values measured for each variant by this process (the 15% species is not shown). (B) To examine the effects of sampling error on the difference measured
between two populations, 103 pairs of frequency measurements were randomly chosen with replacement from the pool of 104 samples generated above for each
value of N. The difference between each pair of samples was calculated using both the percent difference and Nei distance calculations. Lines indicate the upper
and lower limits bounding 95% of the values calculated for each of the distance measures over a range of sample sizes. (C) RT-PCR was performed on 2-fold
serial dilutions of template viral RNA from the plasma of subject 30 (VL = 492732 copies/ml; 2464 RNA molecules were added to the 1 reaction) and the
products were analyzed by V1/V2-HTA. Duplicate sets of RNA dilutions were examined to compare the reproducibility of the HTA patterns at each dilution.
Similar dilutions are in adjacent lanes with the dilution factor noted above.
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is larger than 100, while the variant present at a frequency
of 10% cannot be reliably detected until N is between 30
and 40. Presumably, the same sampling limitations would
be at work in sampling a virus population using RT-PCR,
with the added caveat that the sample size would be
limited by the number of viral genomes that actually
contributed to the PCR reaction, not simply the number
that was added.
This simulation was extended to examine the effects of
sample size on measuring the apparent difference between
two identical samples. For each value of N, 103 pairs of
frequency distributions were chosen with replacement from
the pool of 104 distributions described above. Because both
frequency distributions of each pair are drawn from the
same starting population, the expected value of the differ-
ence between any pair is zero. However, the actual value of
this difference is determined by the extent of sampling error.
The bdistanceQ between two samples can be quantified
based on the frequency (i.e., relative abundance) of the
distinct variants in each sample. This distance was
calculated using both the percent difference and Nei’s
genetic distance (Nei, 1972) calculations. Fig. 5B demon-
strates that the distance between two identical populations as
measured by percent difference will remain nonzero even
for sample sizes of 1000; Nei distance approaches zero for
sample sizes over 200–300. It is notable that even forsample sizes as large as 100 the apparent percent difference
between two samples drawn from the same population
averages 10%, and sample sizes of 10 and 20 have average
percent differences averaging in the 25–30% range for
identical populations.
The findings of this simulation were tested by
performing RT-PCR on 2-fold serial dilutions of viral
RNA. RNA isolated from the plasma of subject 30 was
diluted in PBS, subjected to RT-PCR, and analyzed by
V1/V2-HTA. Duplicate sets of dilutions and RT-PCR
reactions were performed separately to compare the
reproducibility of the HTA patterns at each dilution.
Similar heteroduplex patterns were present in duplicate
reactions at high RNA concentrations (1 through 1/4),
indicating that good sampling had occurred. However,
this reproducibility began to deteriorate from the 1/8
dilution onward. This demonstrates that inadequate
sampling can give the appearance of differences in virus
populations where none exists. Furthermore, at more
extreme dilutions, only one or a few variants are
detected, demonstrating that inadequate sampling can
give the appearance of homogeneity where a heteroge-
neous population exists. These results demonstrate that a
rigorous assessment of the quality of sampling is critical
to any analysis that suggests either a difference between
two virus populations or detection of a homogeneous
population.
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We present here a comparison of the HIV-1 populations
in paired blood and breast milk samples by V1/V2-HTA,
which demonstrates a lack of compartmentalization. V1/V2-
HTA patterns were similar in the eight pairs of samples for
which adequate sampling could be demonstrated, with no
statistical differences in the relative abundance of variants in
these compartments using the percent difference calculation.
Evaluations of measurement consistency indicated that the
majority of the measured differences occurred for variants
that existed at low relative abundances and that the
distribution of these differences was the same for repeated
breast milk measurements when compared to differences
between blood and breast milk samples. Furthermore,
differences in measurement given by these methods, as
well as computer simulation and template dilution RT-PCR
experiments, illustrate how essential it is that sampling error
be considered in comparing virus populations. These
examples further illustrate the impact of template sampling
in the context of PCR as previously discussed by Liu et al.
(1996).
The simplest means of minimizing the effects of sampling
error is to increase the sample size examined. Because HTA
is able to sample all of the viral genomes that contributed to
the RT-PCR product, minimizing sampling error is one of its
strengths, compared, for example, to cloning and sequencing
PCR products. By including only those samples that can be
validated for adequate template sampling, our analysis is
limited to samples with higher viral loads (Fig. 1), which
may bias our results if compartmentalization exists only in
samples with low viral loads. We have examined the V1/V2
region of env because the high degree of variability in this
region typically identifies a greater number of genotypic
variants within an individual, allowing a more sensitive
assessment of potential population differences between
compartments. As has been seen previously (Kitrinos et
al., 2003), the use of a molecular clone probe (Du151)
increased the sensitivity of the HTA to small genotypic
differences in this highly variable region, demonstrated by
the large number of variants detected in these samples. It is
worth noting that the bending of DNA as recorded by the
HTA is not dependent on an absolute percent difference but
rather on the presence of clustered nucleotide differences or
length differences. Thus querying the variable regions of env
enhances the sensitivity of the HTA as mutations are
frequently concentrated over a short stretch of sequence.
When taken with previous similar evaluations (Kitrinos et
al., 2003), this validates the use of the HTA as a tool to assess
the relative abundance of genotypic variants within complex
populations.
In comparing this study to a recent contradictory report
by Becquart et al. (2002), the sampling issues we have
raised must be considered. In their study, they concluded
that compartmentalization of HIV-1 does exist within breast
milk based on approximately 15 C2–V3 sequences clonedfrom each compartment of three individuals. Referring again
to our simulation, Fig. 5B shows that at small sample sizes it
is unlikely that a difference of zero will be measured
between two identical populations. The large degree of
heterogeneity observed among the HIV-1 env sequences in
both this and the Becquart studies makes sample size even
more critical for accurate comparisons of sample popula-
tions. We were able to show that not only are major variants
present in both compartments at equivalent frequencies, but
also many minor variants. Therefore, we propose that the
discrepancy between this study and that of Becquart et al. is
the result of differences in sampling. Because we have
validated the template sampling for the samples presented
here, we are confident in concluding that little difference
exists between the HIV-1 populations of blood plasma and
breast milk in our specimens.
HIV-1 in breast milk may originate from either the
systemic compartment or from local HIV-1-infected macro-
phages, lymphocytes, and ductal epithelial cells. Virus
production by infected mammary ductal epithelial cells or
lymphoid cells could contribute to compartmentalization via
a founder effect. However, breast milk lymphocytes are
thought to be an unlikely source of virus due to factors in
breast milk believed to inhibit virus replication (McNeely et
al., 1995; Van de Perre et al., 1993) and the observation that
most infected cells in milk are unable to produce infectious
virus (Boulerice et al., 1990). Furthermore, while the
presence of mastitis can increase the virus load of breast
milk (Semba et al., 1999) and thereby influence the
composition of HIV-1 populations in this compartment,
the degree of similarity measured between virus populations
isolated from the two subjects identified as having breast
abnormalities (subjects 57 and 64) is comparable to those
from the remaining six subjects, suggesting that the
presence of mastitis is not responsible for our observations.
Similarly, high titers of anti-HIV-1 antibodies in breast milk
may represent a differential selective pressure in this
compartment. However, the majority of these antibodies
are of the IgG isotype (Van de Perre et al., 1993), likely of
systemic origin, and therefore are unlikely to present a
unique immune selection in the breast milk compartment.
Finally, a direct correlation between plasma virus load and
the risk of HIV-1 infection via breast feeding (John et al.,
2001) strongly supports a relationship between the viruses
in these two compartments.
In summary, this assessment of HIV-1 variants by V1/
V2-HTA demonstrates that both the number and relative
abundance of HIV-1 V1/V2 variants in blood plasma and
breast milk are similar. We have also demonstrated that the
quality of viral template sampling influences the accuracy of
assessing complex virus populations and that sampling must
therefore be validated to support conclusions of difference
or homogeneity. Using the ability of the HTA to validate
template sampling, we can conclude that blood plasma and
breast milk are well equilibrated with little evidence of
compartmentalization.
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Subject samples
Human blood and breast milk samples were obtained
with informed consent from women attending a postnatal
clinic at Lilongwe Central Hospital, Lilongwe, Malawi as
part of a larger study described in greater detail by Hoffman
et al. (2003). Breast milk samples were manually expressed
into sterile containers and separated into lipid, skim milk,
and cellular fractions by centrifugation at 1000  g for 10
min. The virus loads of the blood plasma and the skim milk
fraction of the breast milk samples were determined using
the Roche Amplicor HIV-1 Monitor and the NucliSens HIV-
1 QT assays, respectively. The average CD4+T-cell count
for the eight subjects analyzed was 340 cells/Al (range 227–
468), the average time since delivery was 12.6 months
(range 3–26), and all women were antiretroviral therapy
naive. Two of the eight subjects (57 and 64) were identified
as having breast abnormalities (defined as either rash,
cracked nipples, or mastitis).
RNA extraction and RT-PCR
To remove previously reported inhibitors of the reverse-
transcriptase (RT) reaction (Ghosh et al., 2003; Shepard et
al., 2000) and to concentrate the virus in the breast milk
samples, the skim milk fractions, whose volumes varied
from 0.25 to 1.5 ml, were centrifuged at 25000  g and 4
8C for 1.5 h. The virus pellet was resuspended in 140 Al of
phosphate-buffered saline (PBS) prior to viral RNA
isolation. Blood plasma samples were not concentrated
prior to viral RNA isolation. Viral RNA was extracted from
140 Al of plasma or 140 Al of PBS using a QIAmp viral
RNA kit (Qiagen) according to the manufacturer’s instruc-
tions. Viral RNA was reverse transcribed using the Titan
One-Tube RT-PCR system (Roche), modified as previously
described (Kitrinos et al., 2003). To further increase the
input number of viral RNA templates from the breast milk
samples, 10 Al of eluted viral RNA and 24 U of avian
myeloblastosis virus RT (Roche Molecular Biochemicals)
were used for the cDNA reactions, as compared to 5 Al and
12 U, respectively, for plasma samples.
V1/V2-HTA probe
An HIV-1 clade C V1/V2 env probe was constructed
using previously described V1 and V2 primers (Kitrinos et
al., 2003) to amplify this region from an isolate from
Durban, South Africa (Du151; Williamson et al., 2003). The
PCR product was cloned into the pT7Blue vector using the
Perfectly Blunt cloning kit (Novagen). The Du151 V1/V2-
HTA probe was labeled by digesting 6 Ag of plasmid DNA
with NdeI at 37 8C for 1 h and subsequently filling in the
NdeI overhangs by the addition of 50 ACi of [35S]dATP
(1250 Ci/mmol; NEN Life Science Products), 50 AM dTTP,and 10 U of Klenow fragment of DNA polymerase I, as
described (Kitrinos et al., 2003). After removing unincorpo-
rated nucleotides using a QIAquick PCR purification kit
(Qiagen), the probe was released from the plasmid by
digestion with KpnI at 37 8C for 1 h.
V1/V2-HTA
Heteroduplex annealing reactions, consisting of 8 Al of
RT-PCR product, 1 Al of 10 annealing buffer (10 = 1 M
NaCl, 100 mM Tris–HCl [pH 7.5], 20 mM EDTA), 0.1 AM
V1 and V2 primer, and 1 Al of labeled Du151 probe in a
total volume of 10 Al, were denatured at 95 8C for 2 min
followed by annealing at room temperature for 5 min. The
heteroduplexes were then separated by electrophoresis in a
6% polyacrylamide gel (acrylamide-bisacrylamide, 37.5:1)
in 1 Tris-borate-EDTA buffer. The gels were dried and
exposed to X-ray film or a phosphorimaging screen
(Molecular Dynamics).
Quantitative and statistical analysis of V1/V2-HTA
The signal intensity of each HTA band was measured
using ImageQuant software (Molecular Dynamics) to
analyze captured phosphorscreen images. From these values
the relative abundance of each heteroduplex variant was
calculated as a percent of the total signal of that HTA lane.
The difference between any two samples was assessed using
the percent change calculation (Kitrinos et al., 2003; Nelson
et al., 2000), with bands comprising less than 5% relative
abundance being discarded. Statistical comparisons were
made between groups of percent difference values using
Wilcoxon’s rank sum test.
Template sampling simulation
Simulations of virus population sampling by RT-PCR
were performed using MATLAB (MathWorks, Inc.) as
follows. A starting population of 107 elements composed of
four bvariantsQ having the frequencies of 50%, 25%, 15%,
and 10% was created to represent the viral genotypic
variants circulating in an infected subject. The process of
sampling from a population of circulating virus was
simulated by randomly choosing a sample of N elements
with replacement from the above starting population and
calculating the frequency of each variant in the sample. We
repeated this process 104 times for each of 50 values of N,
ranging logarithmically from 101 to 103. A distribution of
104 values for the frequency of each variant at each sample
size was generated and 95% confidence intervals for each
distribution were determined.
The effects of sampling error on measuring the difference
between two populations were estimated as follows: for
each value of N, 103 pairs were chosen with replacement
from the pool of 104 samples described above. The
bdistanceQ between each of the pairs of samples was
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four distinct variants using both the percent difference and
Nei distance calculations. The percent distance calculation
has been used previously to characterize the difference
between populations in the context of HTA analysis
(Kitrinos et al., 2003; Nelson et al., 2000) and is calculated
as:
100 1
2
Xn
i ¼ 1
jAi  Bij
Nei’s standard genetic distance is used to define the distance
between populations given the allelic frequencies at multiple
loci (Nei, 1972). In this analysis, we used a simplified form
for a single blocusQ, where each discrete band of an HTA is
analogous to an allele:
Ds ¼ ln JAB=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
JAJB
p 
where
JA ¼
Xn
i ¼ 1
A2i ; JB ¼
Xn
i ¼ 1
B2i ; and JAB ¼
Xn
i ¼ 1
AiBi
In both of these formulae, n is the number of variants (i.e.,
HTA bands), and Ai and Bi are the relative abundances of
variant i in populations A and B (i.e., HTA lanes), whereP
Ai =
P
Bi = 1. Using these methods, we generated a
distribution of 103 values for each distance measure at each
value of N and 95% confidence intervals were calculated.Acknowledgments
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